ProCE Banner Activity

PomdeSAR: Early Investigation of the Anti-CD38 Monoclonal Antibody Isatuximab in Combination With Pomalidomide/Dexamethasone in R/R MM

Slideset Download
Conference Coverage
Phase I results suggest isatuximab-based combination safe, clinically active in highly treatment-experienced R/R MM.

Released: June 08, 2017

Expiration: June 07, 2018

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants by

AbbVie

Amgen, Inc.

AstraZeneca

Celgene

Genentech Roche Virology

Halozyme

Incyte

Merck Oncology